Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Beigene Ltd ADR (BGNE)

Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket FinancialNewsMedia - Fri Oct 4, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END

ONCY : 1.1800 (+3.51%)
BGNE : 208.03 (+0.38%)
HCM : 18.62 (+1.31%)
ABBV : 201.68 (+0.60%)
ONC.TO : 1.63 (+1.87%)
ELVN : 28.01 (+1.30%)
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket Newswire.ca - Fri Oct 4, 8:00AM CDT

/CNW/ -- USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...

ONCY : 1.1800 (+3.51%)
BGNE : 208.03 (+0.38%)
HCM : 18.62 (+1.31%)
ABBV : 201.68 (+0.60%)
ONC.TO : 1.63 (+1.87%)
ELVN : 28.01 (+1.30%)
Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket BayStreet.ca - Fri Sep 20, 10:07AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – The surge in...

ONCY : 1.1800 (+3.51%)
BGNE : 208.03 (+0.38%)
EXEL : 34.77 (+1.40%)
ABBV : 201.68 (+0.60%)
ONC.TO : 1.63 (+1.87%)
AMGN : 319.29 (+0.75%)
Healthcare (names I - Z) - Regeneron Pharmaceuticals, Inc_ logo on phone-by Piotr Swat via Shutterstock
Is Regeneron Pharmaceuticals Stock Outperforming the S&P 500? Barchart - Wed Sep 4, 2:49AM CDT

Regeneron Pharmaceuticals has outperformed the broader S&P 500 Index over the past year, and Wall Street analysts remain bullish on the stock’s prospects.

REGN : 829.43 (+0.07%)
$SPX : 5,782.76 (+1.23%)
$SPX : 5,782.76 (+1.23%)
BGNE : 208.03 (+0.38%)
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? Motley Fool - Mon Jul 22, 9:41AM CDT

The big pharma company's top drug is losing ground, but its dividend keeps rising.

CVS : 55.34 (+1.26%)
UNH : 567.03 (+1.66%)
ABT : 117.73 (+0.07%)
CI : 318.39 (+1.94%)
AZN : 66.27 (-7.22%)
BGNE : 208.03 (+0.38%)
RVNC : 5.84 (+0.52%)
ABBV : 201.68 (+0.60%)
Health Canada Approves BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma Newswire.ca - Wed Feb 7, 5:47AM CST

/CNW/ - BeiGene, Ltd. (Nasdaq: BGNE) (HKEX: 06160) (SSE: 688235), a global biotechnology company, today announced it received Health Canada authorization for...

BGNE : 208.03 (+0.38%)
Adults living with chronic lymphocytic leukemia (CLL) in Ontario and Quebec now have access, through public reimbursement, to BRUKINSA® (zanubrutinib) Newswire.ca - Wed Jan 31, 5:47AM CST

/CNW/ - BeiGene, Ltd. (NASDAQ: BGNE) (HKEX: 06160) (SSE: 688235), a global biotechnology company is pleased to announce that the Governments of Ontario and...

BGNE : 208.03 (+0.38%)
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond Motley Fool - Mon Jan 15, 5:30AM CST

These five biotech companies could have a lot of room to run.

AMGN : 319.29 (+0.75%)
ARGX : 602.47 (+2.34%)
BGNE : 208.03 (+0.38%)
CRSP : 50.36 (-0.45%)
IMVT : 30.32 (+3.06%)
Author
7 Best Cancer Stocks to Invest in Now MarketBeat - Fri Jul 28, 2023

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

EXEL : 34.77 (+1.40%)
GILD : 90.22 (+0.42%)
NVS : 109.38 (-1.03%)
ON : 70.20 (+1.01%)
PFE : 27.99 (+0.83%)
MDCO : 84.90 (-0.07%)
MRK : 101.65 (-0.22%)
KURA : 17.52 (-1.63%)
AZN.LN : 10,114.000 (-8.40%)
BGNE : 208.03 (+0.38%)
Author
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus MarketBeat - Thu Jul 13, 2023

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

GILD : 90.22 (+0.42%)
AMGN : 319.29 (+0.75%)
BMY : 55.95 (+0.90%)
NVS : 109.38 (-1.03%)
BGNE : 208.03 (+0.38%)
JSPR : 22.40 (+1.68%)
VIGL : 3.86 (-0.26%)
ALVR : 0.9899 (+11.60%)
RCUS : 15.29 (-1.74%)
FLACU : 9.50 (+2.48%)

Barchart Exclusives

Valued at $3.43 Trillion, Is Nvidia Stock Really Undervalued? Barchart - 1 hour ago
SoftBank CEO Masayoshi Son has boldly claimed that Nvidia, already worth $3.4 trillion, is undervalued, citing the company's position at the heart of the artificial intelligence revolution. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot